Latest Regulatory Milestones News

Invictus Energy has reached a pivotal milestone by finalising the Petroleum Production Sharing Agreement for its Cabora Bassa Project, setting the stage for exploration and appraisal drilling in Zimbabwe in 2026. Meanwhile, the company has ended its strategic partnership with Al Mansour Holdings and is actively pursuing new funding avenues.

1414 Degrees has made significant strides in developing its Aurora Energy Precinct, securing crucial regulatory approvals for its battery storage system and progressing its battery materials and hydrogen technologies.

QEM Limited is progressing its strategic review of the Julia Creek Vanadium and Energy Project while advancing key environmental studies and managing capital prudently.

Southern Palladium has made significant strides in advancing its Bengwenyama platinum group metals project, completing key drilling and regulatory milestones while securing A$20 million in fresh capital to fund the next development phase.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

ACDC Metals has reported encouraging mineralogy results from its Goschen Central Rare Earth Elements project, reinforcing its strategic value amid rising geopolitical interest. The company maintains a solid cash balance to support ongoing development and exploration activities.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

ioneer Ltd has raised approximately US$50.4 million through an institutional placement to fund the advancement of its Rhyolite Ridge lithium-boron project in Nevada towards a Final Investment Decision in the second half of 2026. The capital injection supports project readiness, environmental permitting, and early works for this strategically significant US critical minerals asset.

HeraMED has secured pivotal US commercial agreements and achieved a key Australian regulatory milestone, positioning itself for scalable growth in digital maternity care.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

QPM Energy has secured key contracts and financing milestones for its 112MW Isaac Power Station, while managing stable gas supply amid weak electricity prices.